CD4 and Huntington disease: 48% of MS patients have in their peripheral blood at least one CD8+ clonotype that is shared by the three demyelinating lesions and 28% of patients at least one CD4+ clonotype, while only 23.5% of HD have at least one CD8+ clonotype in their peripheral blood that is shared by the three demyelinating lesions, and 11.7% at least one CD4+ clonotype.